Skip to main content

Table 4 Landmark Analysis: Predictors of readmission from 31-365 days after discharge

From: Association between transitional care factors and hospital readmission after transcatheter aortic valve replacement: a retrospective observational cohort study

 

HR

95% CI

p value

Demographics

 Age

1.00

(0.99 - 1.01)

0.67

 Female sex

0.92

(0.61 - 1.40)

0.70

 Dependent living

0.93

(0.72 - 1.20)

0.56

Clinical Characteristics

 NYHA class

  I/II

reference

  

  III

1.15

(0.83 - 1.61)

0.40

  IV

1.68

(1.06 - 2.66)

0.03

 Frailty

0.87

(0.66 - 1.13)

0.30

Cardiac comorbidities and interventions

 Atrial fibrillation

1.30

(1.02 - 1.65)

0.03

 Prior heart failure

1.02

(0.83 - 1.26)

0.84

 Prior myocardial infarction

0.97

(0.68 - 1.39)

0.87

 PCI

1.02

(0.73 - 1.43)

0.92

 CABG

0.96

(0.76 - 1.22)

0.73

Medical comorbidities

 Diabetes

0.96

(0.63 - 1.48)

0.86

 Cerebrovascular disease

0.70

(0.50 - 0.98)

0.04

 Peripheral vascular disease

1.27

(1.02 - 1.57)

0.03

 Dementia

1.03

(0.60 - 1.78)

0.90

 Dialysis

2.01

(0.90 - 4.48)

0.09

 Lung disease

1.33

(1.08 - 1.65)

0.01

 Liver disease

1.52

(0.43 - 5.36)

0.51

 Peptic ulcer disease

1.86

(1.29 - 2.67)

<0.001

 History of bleeding

1.08

(0.79 - 1.47)

0.63

Laboratory markers

 eGFR

0.99

(0.99 - 1.00)

0.14

 Hemoglobin

0.99

(0.99 - 1.00)

<0.001

Echocardiographic findings

 Left ventricular dysfunction

0.76

(0.57 - 1.02)

0.07

Procedural characteristics

 Urgent procedure

1.10

(0.66 - 1.81)

0.72

 Valve in valve

0.49

(0.29 - 0.83)

0.01

 Self-expandable prosthesis

1.15

(0.89 - 1.48)

0.29

 Non-femoral vascular access site

1.17

(0.78 - 1.75)

0.44

 TAVR year

0.99

(0.90 - 1.10)

0.90

Procedural complications

 Stroke

1.78

(1.22 - 2.60)

0.003

 Permanent pacemaker

0.97

(0.53 - 1.76)

0.91

 Delirium

1.40

(0.95 - 2.06)

0.09

 Bleeding, vascular complication or transfusion

1.29

(1.22 - 1.37)

<0.001

Echocardiographic findings post-TAVR

 Mitral regurgitation

  Nil/trace

reference

  

  Mild

1.06

(0.95 - 1.20)

0.30

  Moderate/Severe

1.27

(0.97 - 1.66)

0.08

 Aortic regurgitation

  Nil/trace

reference

  

  Mild

1.25

(0.95 - 1.64)

0.11

  Moderate/Severe

1.29

(0.77 - 2.15)

0.34

Previous health resource utilization

 Hospitalization 30 days before TAVR

1.21

(0.91 - 1.61)

0.20

Transitional care factors in first 30 days

 Rehabilitation

1.55

(1.37 - 1.75)

<0.001

 Home care

0.94

(0.78 - 1.13)

0.51

 Family physician follow-up

0.73

(0.51 - 1.05)

0.09

 Cardiologist follow-up

1.13

(0.89 - 1.42)

0.32

  1. Abbreviations: NYHA New York Heart Association, PCI percutaneous coronary intervention, CABG coronary-aorto bypass grafting